Sonova Holding AGXSWX:SOON +0.79%90 3-Year ROIIC % is 81.12 as of Mar. 2026, which is 491% above its 10-year median of 13.73. GuruFocus rates XSWX:SOON with a GF Score™ of 90/100 and a GF Value™ of CHF249.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Sonova Holding AG ranks better than 87.36% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Sonova Holding AG's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 81.12%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Sonova Holding AG's 3-Year ROIIC % or its related term are showing as below:
XSWX:SOON's 3-Year ROIIC % is ranked better than 87.36% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.78
vs XSWX:SOON: 81.12
Sonova Holding AG (XSWX:SOON) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sonova Holding AG 3-Year ROIIC % Related Terms
Sonova Holding AG 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Sonova Holding AG's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SOON vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Sonova Holding AG's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonova Holding AG 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sonova Holding AG's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Sonova Holding AG's 3-Year ROIIC % falls into.
Sonova Holding AG's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 575.12331 (Mar. 2026) - 686.90664 (Mar. 2023) )
/
( 4548.3 (Mar. 2026) - 4686.1 (Mar. 2023) )
=
-111.78333
/
-137.8
=
81.12%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sonova Holding AG (XSWX:SOON) has a 3-Year ROIIC % of 81.12 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sonova Holding AG and its competitors. This is 491% above median its historical median of 13.73. According to the industry distribution chart, Sonova Holding AG ranks #101 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 12.6%.
Is Sonova Holding AG's 3-Year ROIIC % too high?
Sonova Holding AG's current 3-Year ROIIC % of 81.12 is 491% above median its 10-year median of 13.73. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.78. Sonova Holding AG's value of 81.12 is 4457.3% above this industry median. Based on the distribution chart, Sonova Holding AG ranks #101 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sonova Holding AG has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonova Holding AG's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sonova Holding AG ranks #101 out of 799 companies for 3-Year ROIIC %. This places Sonova Holding AG in the top 13% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.78. Sonova Holding AG's value of 81.12 is 4457.3% above this benchmark. While the company's 10-year median is 13.73 vs. the industry median of 1.78, Sonova Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.78, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonova Holding AG's current 3-Year ROIIC % of 81.12 is 4457.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sonova Holding AG and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonova Holding AG's current 3-Year ROIIC % is 81.12, which is 491% above median its own 10-year median of 13.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonova Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Sonova Holding AG (XSWX:SOON) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF249.97, compared to a current price of CHF203.60 — trading 18.6% below its estimated fair value. The current 3-Year ROIIC % is 81.12, which is 491% above median its 10-year median of 13.73 and 4457.3% above the Medical Devices & Instruments industry median of 1.78. Sonova Holding AG's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Sonova Holding AG (XSWX:SOON), the current 3-Year ROIIC % is 81.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sonova Holding AG (XSWX:SOON) Overvalued in 2026?
Based on GuruFocus' analysis, Sonova Holding AG stock appears to be undervalued.
The current stock price of CHF203.60 is trading 18.6% below its estimated GF Value™ of CHF249.97.
GuruFocus considers Sonova Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SOON:
3-Year ROIIC %: 81.12 (491% above median its 10-year median of 13.73)
GF Value™: CHF249.97 vs. price of CHF203.60 (18.6% below fair value)
Industry Position: 4457.3% above the Medical Devices & Instruments median (#101 of 799)
No single metric tells the full story. See the XSWX:SOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
90GF Score
Get the complete analysis for XSWX:SOON
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SOON has been successfully added to your 
